MADRE (Mammograms Available Due to Research and Education)
ConditionBreast Cancer Screening
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age40-74
SponsorUniversity of Illinois at Chicago
About this trial
The design builds on past studies by integrating social network analysis (SNA) and implementation science (IS) into a longitudinal randomized clinical trial (RCT). The investigator will compare the long-term effects of interventions by examining guideline-concordant initial and repeat Breast Cancer (BC) screening.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
female biological sex
identification as Latinas
non-adherence to USPSTF guidelines (42-74 years old, no mammogram in past 2 years, no previous BC diagnosis)
no previous history of health volunteerism
Disqualifiers
female biological sex
eligibility to obtain BC screenings by USPSTF guidelines (i.e., 40-74 years old, no personal BC history)
referral from Aim 1 participants
no previous history of health volunteerism
Trial design
Design model
Parallel
Treatments tested in this trial
Educate
Other interventionEducation sessions
Empower
Other interventionEmpowerment sessions
Treatment groups
600 Participants
are divided into 2 treatment groupsGroup A: Educate (Education + Navigation) SessionsOther 1 intervention
Group B: Empower (Empowerment + Navigation) SessionsOther 1 intervention
Trial outcomes
Primary outcomes
1
Breast Cancer (BC) Screening (Aim 1)
Compare the number of participants in the empowerment arm that obtain guideline-concordant initial and repeat BC screening with the the number of participants in the education arm
Time frame
1-4 years2
Breast Cancer Screening (Aim 2)
Compare the number of network members in the empowerment arm that obtain guideline-concordant initial and repeat BC screening with the number of non-adherent network members in the education arm
Time frame
1-4 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov